跳至主要内容
临床试验/NCT00716560
NCT00716560终止不适用

Nausea and Vomiting In Patients Receiving Consecutive Days of Cisplatin

Sidney Kimmel Cancer Center at Thomas Jefferson University1 个研究点 分布在 1 个国家目标入组 8 人开始时间: 2005年5月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
8
试验地点
1
主要终点
Determine incidence of nausea when receiving Dartmouth regimen chemotherapy for metastatic melanoma

研究概览

简要总结

The purpose of this study is to observe the incidence of nausea with systemic chemotherapy that includes consecutive days (more than one day)of cisplatin medication.

详细描述

Questionnaires are completed on week of chemotherapy treatment referred to as Dartmouth regimen.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • confirmed diagnosis metastatic melanoma
  • 18 years and older
  • undergoing chemotherapy with Dartmouth regimen
  • medically stable to receive chemotherapy per physical and clinical laboratory tests

排除标准

  • No medical conditions that interfere with assessment of nausea and vomiting during chemotherapy
  • No cognitive disorder that impairs symptom assessment
  • No other investigational agent
  • Inability to swallow medications for nausea and vomiting
  • No gastric outlet obstruction

结局指标

主要结局

Determine incidence of nausea when receiving Dartmouth regimen chemotherapy for metastatic melanoma

时间窗: Week of treatment

次要结局

  • Assess the impact of systemic chemotherapy with Dartmouth regimen on quality of life of patients(week of treatment)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Nausea and Vomiting In Patients Receiving... | 临床试验